Cargando…
Treating the dysfunctional placenta
Placental dysfunction underlies major obstetric diseases such as pre-eclampsia and fetal growth restriction (FGR). Whilst there has been a little progress in prophylaxis, there are still no treatments for placental dysfunction in normal obstetric practice. However, a combination of increasingly well...
Autor principal: | Sibley, Colin P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516438/ https://www.ncbi.nlm.nih.gov/pubmed/28483805 http://dx.doi.org/10.1530/JOE-17-0185 |
Ejemplares similares
-
A Review of Nanotechnology for Treating Dysfunctional Placenta
por: Jiang, Huabo, et al.
Publicado: (2022) -
Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction
por: Renshall, Lewis J., et al.
Publicado: (2021) -
Dysregulated flow-mediated vasodilatation in the human placenta in fetal growth restriction
por: Jones, Sarah, et al.
Publicado: (2015) -
A Case of Placenta Prævia Treated by Partial Separation of Placenta and Ergot: Recovery
por: Roy, G. C.
Publicado: (1881) -
Placenta Prævia Treated by Digital Compression
Publicado: (1872)